<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03117491</url>
  </required_header>
  <id_info>
    <org_study_id>395437</org_study_id>
    <nct_id>NCT03117491</nct_id>
  </id_info>
  <brief_title>Effect of Inferior Alveolar and Gow-Gates Nerve Block Techniques for Symptomatic Mandibular Molars</brief_title>
  <official_title>Effect of Inferior Alveolar and Gow-Gates Nerve Block Techniques for Symptomatic Mandibular Molars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isfahan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: to evaluate the efficacy of inferior alveolar nerve block (IANB), Gow-Gates
      nerve block (GGNB), and their combination in patients with irreversible pulpitis. Methods:
      One hundred fifty subjects with irreversible pulpitis of a mandibular molar were selected.
      subjects randomly received two IANB injections or two GGNB injections or their combination of
      1.8 mL 2% lidocaine with 1:100,000 epinephrine. Success was specified as no or mild pain on
      the basis of Heft-Parker visual analogue scale recordings up on the access cavity preparation
      or initial instrumentation. Data were analyzed by Kruskal-Wallis, and ANOVA tests.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: to evaluate the efficacy of inferior alveolar nerve block (IANB), Gow-Gates
      nerve block (GGNB), and their combination in patients with irreversible pulpitis. Methods:
      One hundred fifty subjects with irreversible pulpitis of a mandibular molar were selected.
      subjects randomly received two IANB injections or two GGNB injections or their combination of
      1.8 mL 2% lidocaine with 1:100,000 epinephrine. Success was specified as no or mild pain on
      the basis of Heft-Parker visual analogue scale recordings up on the access cavity preparation
      or initial instrumentation. Data were analyzed by Kruskal-Wallis, and ANOVA tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2015</start_date>
  <completion_date type="Actual">December 1, 2016</completion_date>
  <primary_completion_date type="Actual">November 1, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the success rate of GGNB local anesthesia technique based on Heft-Parker visual analog scale</measure>
    <time_frame>at time of access cavity preparation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>the success rate of IANB local anesthesia technique based on Heft-Parker visual analog scale</measure>
    <time_frame>at time of access cavity preparation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>the success rate of GGNB + IANB local anesthesia techniques based on Heft-Parker visual analog scale</measure>
    <time_frame>at time of access cavity preparation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>initial pain based on Heft-Parker visual analog scale</measure>
    <time_frame>before treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Symptomatic Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>GGNB injection technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In GGNB group, every patient received two1.8-mL cartridges of 2% lidocaine with 1:80,000 epinephrine using the GGNB technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IANB injection technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In IANB group, every patient received two 1.8-mL cartridges of 2% lidocaine with 1:80,000 epinephrine using the IANB technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GGNB + IANB injection technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In IANB + GGNB group, every patient received one 1.8-mL cartridges of 2% lidocaine with 1:80,000 epinephrine using the IANB technique and one 1.8-mL cartridges of 2% lidocaine with 1:80,000 epinephrine using the GGNB technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>GGNB injections</intervention_name>
    <description>The patients received two GGNB injections of 1.8 mL 2% lidocaine with 1:100,000 epinephrine</description>
    <arm_group_label>GGNB injection technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IANB injections</intervention_name>
    <description>The patients received two IANB injections of 1.8 mL 2% lidocaine with 1:100,000 epinephrine</description>
    <arm_group_label>IANB injection technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>GGNB + IANB injections</intervention_name>
    <description>The patients received one GGNB injection plus one IANB injection of 1.8 mL 2% lidocaine with 1:100,000 epinephrine</description>
    <arm_group_label>GGNB + IANB injection technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  vital mandibular molar tooth

          -  diagnosis of symptomatic irreversible pulpitis

        Exclusion Criteria:

          -  younger than 18 years old

          -  history of significant medical conditions

          -  allergies to local anesthetics or sulfites

          -  pregnancy

          -  taking any medications that might influence anesthetic assessment

          -  active sites of pathosis in area of injection

          -  inability to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Isfahan University of Medical Sciences</name>
      <address>
        <city>Isfahan</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 3, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2017</study_first_posted>
  <last_update_submitted>May 4, 2017</last_update_submitted>
  <last_update_submitted_qc>May 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isfahan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Masoud Saatchi, DDS MSc</investigator_full_name>
    <investigator_title>Professor of Endodontics</investigator_title>
  </responsible_party>
  <keyword>Gow-Gates nerve block</keyword>
  <keyword>Inferior alveolar nerve block</keyword>
  <keyword>local anesthesia</keyword>
  <keyword>molar</keyword>
  <keyword>pulpitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

